Kay Warner

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes

David Haerry, Cordula Landgraf, Kay Warner et al. · Frontiers in Medicine · 2018 · 81 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +17

EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment

Amy Hunter, Karen Facey, Victoria Thomas et al. · Frontiers in Medicine · 2018 · 72 citations · Full text

Public Affairs, Health Policy, Pharmacoeconomics +15

EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D

Kay Warner, Wolf See, David Haerry et al. · Frontiers in Medicine · 2018 · 72 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +14

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials

Ingrid Klingmann, Andrea Heckenberg, Kay Warner et al. · Frontiers in Medicine · 2018 · 35 citations · Full text

Public Health, Pharmacology, Ethics +16

What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study

Suzanne Parsons, Bella Starling, Christine Mullan-Jensen et al. · BMJ Open · 2016 · 32 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +8